High-risk penetrating keratoplasty
Background: Loss of immune privilege has important connotations for graft survival, often in clinical scenarios where the other eye is irreversibly blind. This article looks at the state of the evidence-based treatment available for high-risk penetrating keratoplasty (P.K.). Materials and Methods: R...
Main Authors: | Shilpa Ajit Joshi, Madan Deshpande |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Clinical Ophthalmology and Research |
Subjects: | |
Online Access: | http://www.jcor.in/article.asp?issn=2320-3897;year=2016;volume=4;issue=3;spage=163;epage=170;aulast=Joshi |
Similar Items
-
CORNEAL GRAFT REJECTION AFTER KERATOPLASTY
by: S. V. Trufanov, et al.
Published: (2017-10-01) -
Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty
by: Said OM, et al.
Published: (2020-10-01) -
Cytomegalovirus Endotheliitis After Penetrating Keratoplasty
by: Tuna Çelik Büyüktepe, et al.
Published: (2020-10-01) -
Graft rejection in pediatric penetrating keratoplasty: Clinical features and outcomes
by: Rakhi Kusumesh, et al.
Published: (2015-01-01) -
Deep anterior lamellar keratoplasty in dematiaceous keratomycosis
by: Shilpa Ajit Joshi, et al.
Published: (2016-01-01)